These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 27429846)
1. Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma. Su TJ; Ku WH; Chen HY; Hsu YC; Hong QS; Chang GC; Yu SL; Chen JJ Am J Cancer Res; 2016; 6(6):1317-30. PubMed ID: 27429846 [TBL] [Abstract][Full Text] [Related]
2. miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9. Wu L; Pu X; Wang Q; Cao J; Xu F; Xu LI; Li K Oncol Lett; 2016 Feb; 11(2):945-952. PubMed ID: 26893673 [TBL] [Abstract][Full Text] [Related]
3. Synergistic antitumor activity of pro-apoptotic agent PAC-1 with cisplatinum by the activation of CASP3 in pulmonary adenocarcinoma cell line H1299. Huang JQ; Liang HL; Zhang XC; Xie Z; Jin TE Asia Pac J Clin Oncol; 2016 Mar; 12(1):41-51. PubMed ID: 26620316 [TBL] [Abstract][Full Text] [Related]
4. Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer. Cui Y; Li G; Zhang X; Dai F; Zhang R Oncol Lett; 2018 Oct; 16(4):4821-4828. PubMed ID: 30250547 [TBL] [Abstract][Full Text] [Related]
5. miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin. Chen X; Jiang Y; Huang Z; Li D; Chen X; Cao M; Meng Q; Pang H; Sun L; Zhao Y; Cai L Sci Rep; 2016 Jan; 6():19455. PubMed ID: 26781643 [TBL] [Abstract][Full Text] [Related]
6. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2. Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2. Xie J; Yu F; Li D; Zhu X; Zhang X; Lv Z Tumour Biol; 2016 Jan; 37(1):1197-204. PubMed ID: 26282001 [TBL] [Abstract][Full Text] [Related]
8. miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells. Zhao Z; Zhang L; Yao Q; Tao Z Cancer Gene Ther; 2015 Apr; 22(3):108-14. PubMed ID: 25721211 [TBL] [Abstract][Full Text] [Related]
9. MiR-129-5p inhibits non-small cell lung cancer cell stemness and chemoresistance through targeting DLK1. Ma Z; Cai H; Zhang Y; Chang L; Cui Y Biochem Biophys Res Commun; 2017 Aug; 490(2):309-316. PubMed ID: 28619508 [TBL] [Abstract][Full Text] [Related]
10. Deregulation of lncRNA-AC078883.3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN/AKT. Xing S; Qu Y; Li C; Huang A; Tong S; Wu C; Fan K J Cell Physiol; 2019 Dec; 234(12):22657-22665. PubMed ID: 31111480 [TBL] [Abstract][Full Text] [Related]
11. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1. Zhang H; Hu B; Wang Z; Zhang F; Wei H; Li L Cancer Chemother Pharmacol; 2017 Nov; 80(5):973-984. PubMed ID: 28956120 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA 192 regulates chemo-resistance of lung adenocarcinoma for gemcitabine and cisplatin combined therapy by targeting Bcl-2. Cao J; He Y; Liu HQ; Wang SB; Zhao BC; Cheng YS Int J Clin Exp Med; 2015; 8(8):12397-403. PubMed ID: 26550150 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2. Seidl C; Panzitt K; Bertsch A; Brcic L; Schein S; Mack M; Leithner K; Prinz F; Olschewski H; Kornmueller K; Hrzenjak A Cancer Lett; 2020 Jan; 469():266-276. PubMed ID: 31697978 [TBL] [Abstract][Full Text] [Related]
14. The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis. Chen L; Han X; Hu Z; Chen L Cancer Chemother Pharmacol; 2019 May; 83(5):921-931. PubMed ID: 30859368 [TBL] [Abstract][Full Text] [Related]
15. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer. Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644 [TBL] [Abstract][Full Text] [Related]
16. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes. Li X; Chen W; Jin Y; Xue R; Su J; Mu Z; Li J; Jiang S Biochem Pharmacol; 2019 Mar; 161():98-112. PubMed ID: 30639456 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-103a-3p potentiates chemoresistance to cisplatin in non-small cell lung carcinoma by targeting neurofibromatosis 1. Zhu H; Yang J; Yang S Exp Ther Med; 2020 Mar; 19(3):1797-1805. PubMed ID: 32104235 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy. Hua L; Zhu G; Wei J Cell Biol Int; 2018 Sep; 42(9):1240-1249. PubMed ID: 29851226 [TBL] [Abstract][Full Text] [Related]
19. miR-198-induced upregulation of Livin may be associated with the prognosis and contribute to the oncogenesis of lung adenocarcinoma. Liang Y; Wang H; Sun Y; Chen S; Wang H; Huang R; Zhao X; Fu W; Yang C Oncol Rep; 2017 Oct; 38(4):2096-2104. PubMed ID: 28765921 [TBL] [Abstract][Full Text] [Related]
20. TNFAIP2 Promotes Non-Small Cell Lung Cancer Cells and Targeted by miR-145-5p. Li J; Song Y; Yu B; Yu Y DNA Cell Biol; 2020 Jul; 39(7):1256-1263. PubMed ID: 32456459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]